Myriad Genetics MYGN Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's number of exercisable options?
- Myriad Genetics (MYGN) reported number of exercisable options of 500K in Q1 2026.
- How has Myriad Genetics's number of exercisable options changed year-over-year?
- Myriad Genetics's number of exercisable options decreased by 0.0% year-over-year, from 500K to 500K.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.